ArticleNAM journal2026
Metabolism-dependent drug response assessment using a liver-cancer microphysiological system on the kinetic-pump integrated microfluidic plate (KIM-Plate).
Article in NAM journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reducing reliance on animal studies while improving human relevance requires new approach methodologies (NAMs) that reproduce dynamic biological interactions and metabolism-dependent drug exposure. Microphysiological systems (MPSs) are promising NAMs that can recapitulate selected human organ functions in vitro. However, the advantages of multi-organ MPSs over conventional culture methods have not been sufficiently validated because direct comparisons between these systems are difficult. Here, we constructed a liver-cancer MPS using a Kinetic-pump integrated microfluidic plate (KIM-Plate) containing two open, standard-well-compatible culture chambers connected by recirculating microchannels. PXB human hepatocytes and MCF7 breast cancer cells were evaluated using well-plate monoculture, conditioned-medium transfer, KIM-Plate monoculture, and dynamic KIM-Plate coculture. Dynamic coculture significantly increased MCF7 proliferation relative to KIM-Plate monoculture, whereas conditioned-medium transfer did not significantly increase proliferation relative to well-plate monoculture. PXB cells produced the active CPT-11 metabolite SN-38 and SN-38 glucuronide under both static and perfusion conditions, demonstrating sequential CPT-11-metabolizing activity in the MPS. MCF7 cells showed greater apparent sensitivity to SN-38 under perfusion than under static conditions. During CPT-11 exposure, the dynamic liver-cancer coculture was estimated to generate a gradually increasing SN-38 exposure profile and a lower SN-38 area under the concentration-time curve than conditioned-medium exposure. Nevertheless, observed MCF7 viability was higher than predicted from cumulative SN-38 exposure alone, suggesting that the temporal exposure profile may also have contributed to the drug response. The KIM-Plate therefore provides a tractable human cell-based NAM for investigating how continuous intercellular interactions, perfusion, and time-dependent metabolism collectively influence drug responses, thereby providing mechanistically informative evidence for metabolism-dependent drug assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.